The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: Collaborative reanalysis of individual data on 8,097 women with squamous cell carcinoma and 1,374 women with adenocarcinoma from 12 epidemiological studies
Open accessAbstract
Squamous cell carcinomas account for about 80% of cancers of the uterine cervix, and the majority of the remainder are adenocarcinomas. There is limited evidence on the extent to which these histological types share a common etiology. The International Collaboration of Epidemiological Studies of Cervical Cancer has brought together and combined individual data on 8,097 women with invasive squamous cell carcinoma, 1,374 women with invasive adenocarcinoma and 26,445 women without cervical cancer (controls) from 12 epidemiological studies. Compared to controls, the relative risk of each histological type of invasive cervical cancer was increased with increasing number of sexual partners, younger age at first intercourse, increasing parity, younger age at first full‐term pregnancy and increasing duration of oral contraceptive use. Current smoking was associated with a significantly increased risk of squamous cell carcinoma (RR = 1.50, 95% CI: 1.35–1.66) but not of adenocarcinoma (RR = 0.86 (0.70–1.05)), and the difference between the two histological types was statistically significant (case‐case comparison p < 0.001). A history of screening (assessed as having had at least one previous nondiagnostic cervical smear) was associated with a reduced risk of both histological types, but the reduction was significantly greater for squamous cell carcinoma than for adenocarcinoma (RR = 0.46 (0.42–0.50) and 0.68 (0.56–0.82), respectively; case–case comparison, p = 0.002). A positive test for cervical high‐risk HPV‐DNA was a strong risk factor for each histological type, with 74% of squamous cell carcinomas and 78% of adenocarcinomas testing positive for HPV types 16 or 18. Squamous cell and adenocarcinoma of the cervix share most risk factors, with the exception of smoking. © 2006 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer Incidence in Five Continents
(1970) · Springer eBooks · doi:10.1007/978-3-642-85851-2 · Cited by 8,501
Epidemiologic classification of human papillomavirus types associated with cervical cancer
Muñoz, N., Bosch, F. X., de Sanjosé, S., Herrero, R., Castellsagué, X., Shah, K. V., Snijders, P. J. F., & Meijer, C. J. L. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021641 · Cited by 6,249
Cancer Incidence in Five Continents
(1966) · doi:10.1007/978-3-642-85849-9 · Cited by 5,936
Breast cancer and hormone-replacement therapy in the Million Women Study
(2003) · The Lancet · doi:10.1016/s0140-6736(03)14065-2 · Cited by 2,993
Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis
Clifford, G. M., Smith, J. S., Plummer, M., Muñoz, N., & Franceschi, S. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600688 · Cited by 1,561
Breast cancer and hormone-replacement therapy: the Million Women Study
Beral, V., Banks, E., Reeves, G., & Bull, D. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14596-5 · Cited by 1,273
Castellsagué, X., Díaz, M., de Sanjosé, S., Muñoz, N., Herrero, R., Franceschi, S., Peeling, R. W., Ashley, R., Smith, J. S., Snijders, P. J. F., et al. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj067 · Cited by 688
International Collaboration of Epidemiological Studies of Cervical Cancer (2006) · International Journal of Cancer · doi:10.1002/ijc.21493 · Cited by 464
Human papillomavirus and invasive cervical cancer in Brazil
Eluf-Neto, J., Booth, M., Muñoz, N., Bosch, F., Meijer, C., & Walboomers, J. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.18 · Cited by 268
International Collaboration of Epidemiological Studies of Cervical Cancer (2006) · International Journal of Cancer · doi:10.1002/ijc.21953 · Cited by 266
Cited by
Human papillomavirus and cervical cancer
Schiffman, M., Castle, P. E., Jeronimo, J., Rodriguez, A. C., & Wacholder, S. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61416-0 · Cited by 2,985
Cohen, P. A., Jhingran, A., Oaknin, A., & Denny, L. (2019) · The Lancet · doi:10.1016/s0140-6736(18)32470-x · Cited by 2,412
Saslow, D., Solomon, D., Lawson, H. W., Killackey, M., Kulasingam, S. L., Cain, J., Garcia, F. A. R., Moriarty, A. T., Waxman, A. G., Wilbur, D. C., et al. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21139 · Cited by 1,390
Saslow, D., Solomon, D., Lawson, H. W., Killackey, M., Kulasingam, S. L., Cain, J. M., Garcia, F. A. R., Moriarty, A. T., Waxman, A. G., Wilbur, D. C., et al. (2012) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0b013e31824ca9d5 · Cited by 915
Saslow, D., Solomon, D., Lawson, H. W., Killackey, M., Kulasingam, S. L., Cain, J., Garcia, F. A. R., Moriarty, A. T., Waxman, A. G., Wilbur, D. C., et al. (2012) · American Journal of Clinical Pathology · doi:10.1309/ajcptgd94evrsjcg · Cited by 791
Cancer statistics for Hispanics/Latinos, 2012
Siegel, R., Naishadham, D., & Jemal, A. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21153 · Cited by 655
Cervical cancer in low and middle‑income countries (Review)
Hull, R., Mbele, M., Makhafola, T., Hicks, C., Wang, S., Reis, R., Mehrotra, R., Mkhize‑Kwitshana, Z., Kibiki, G., Bates, D., et al. (2020) · Oncology Letters · doi:10.3892/ol.2020.11754 · Cited by 544
Pinsky, P. F., Church, T. R., Izmirlian, G., & Kramer, B. S. (2013) · Cancer · doi:10.1002/cncr.28326 · Cited by 293
Roura, E., Castellsagué, X., Pawlita, M., Travier, N., Waterboer, T., Margall, N., Bosch, F. X., de Sanjosé, S., Dillner, J., Gram, I. T., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.28666 · Cited by 283
Metadata
- Authors
- The International Collaboration of Epidemiological Studies of Cervical Cancer
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2006-12-27
- Volume
- 120
- Issue
- 4
- Pages
- 885-891
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W49316204
- Cited by
- 404
- References
- 28
- FWCI
- 6.64
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.